ALMIRALL, S.A. «...1617» Page 16 out of 17 20/07/2020 17:37 ALMIRALL, S.A. Other relevant information Almirall refinancia la línea de crédito revolving Register number: 3488 25/06/2020 19:15 ALMIRALL, S.A. Other relevant information Almirall S.A. divests Ansiolin® to Neuraxpharm in Italy Register number: 2996 10/06/2020 17:39 ALMIRALL, S.A. Announcement of general shareholders’ meeting Convocatoria Junta General Ordinaria para su celebración por medios exclusivamente telemáticos Register number: 2695 11/05/2020 07:36 ALMIRALL, S.A. Other relevant information Conference Call with analysts and Institutional investors Register number: 2150 11/05/2020 07:26 ALMIRALL, S.A. Interim management report La sociedad remite declaración intermedia de gestión del primer trimestre de 2020 Register number: 2149 06/05/2020 18:19 ALMIRALL, S.A. Liquidity and counterparty agreements Operaciones del contrato de liquidez durante el primer trimestre de 2020 Register number: 2074 24/03/2020 17:44 ALMIRALL, S.A. Announcement of general shareholders’ meeting Ordinary Shareholders Meeting Register number: 1166 09/03/2020 12:11 ALMIRALL, S.A. On business and financial situation Almirall announces FDA acceptance for filing of U.S. New Drug Application (NDA) for tirbanibulin in actinic keratosis Register number: 804 02/03/2020 08:45 ALMIRALL, S.A. On business and financial situation Almirall announces EMA acceptance for filing of Marketing Authorization Application (MAA) for tirbanibulin in actinic keratosis Register number: 680 24/02/2020 07:28 ALMIRALL, S.A. On corporate governance Otra Información Relevante sobre modificación del Reglamento Interno de Conducta en el Mercado de Valores de Almirall Register number: 198 Page 16 out of 17 «...1617»